Chatham Capital Group, Inc. Laboratory Corp Of America Holdings Transaction History

Chatham Capital Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	BUY	$209.01 - $232.56 $209 - $232	1 Added 0.08%	1,238 $270,000
Q4 2023 Jan 19, 2024	BUY	$197.69 - $227.29 $197 - $227	1 Added 0.08%	1,237 $281,000
Q1 2023 Apr 21, 2023	BUY	$213.32 - $257.83 $213 - $257	1 Added 0.08%	1,236 $283,000
Q1 2022 Apr 21, 2022	SELL	$259.82 - $298.18 $51,964 - $59,636	-200 Reduced 13.94%	1,235 $326,000
Q2 2020 Jul 20, 2020	BUY	$113.31 - $182.44 $162,599 - $261,801	1,435 New	1,435 $238,000
Q1 2020 May 01, 2020	SELL	$104.32 - $195.28 $149,699 - $280,226	-1,435 Closed	0 $0
Q1 2019 May 09, 2019	BUY	$123.7 - $156.3 $177,509 - $224,290	1,435 New	1,435 $220,000
Q4 2018 Feb 06, 2019	SELL	$120.82 - $174.09 $182,438 - $262,875	-1,510 Closed	0 $0
Q2 2017 Aug 09, 2017	BUY	N/A	1,510	1,510 $233,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Chatham Capital Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Chatham Capital Group, Inc. with notifications on news.